Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles.
about
Targeted approaches to induce immune tolerance for Pompe disease therapyAdeno-associated Virus as a Mammalian DNA VectorAdeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveDevelopment of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene TransferAdenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.Influence of immune responses in gene/stem cell therapies for muscular dystrophies.Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanismsOptimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variantsControlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of CancerInduction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep.Prediction of adeno-associated virus neutralizing antibody activity for clinical application.Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.An emerging adeno-associated viral vector pipeline for cardiac gene therapyHeparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applicationsPromise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesPre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors.Recent advances in gene therapy for lysosomal storage disorders.Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding SiteRationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection.scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye.Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors.Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier.AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement.
P2860
Q26767363-51D269F4-5475-47D9-93E1-8B7833B034B9Q26782605-DF060BAE-9613-40A1-8897-CC0105F43062Q27012320-49998711-34B9-405F-8CFA-196121683EF6Q30152887-188EB399-CE40-477D-977B-8C623E4A5F48Q30605561-59B8C68E-5891-479F-B0CD-7907E24C6DB7Q33736192-F86F7913-556F-4109-9B4F-872E2CC0908AQ34370111-E25D4330-EC02-472F-B955-58EDF140CC27Q34593758-6E9453B4-A9DD-4859-B175-1FBC4594BDE3Q34634722-43D0D278-F01D-4D5E-98A0-9FEBF8E2F1D5Q34700925-05F72659-BED1-4D4D-8A75-1071F3500C4CQ34979802-B6107EF0-CB06-4BE2-8483-ACF006A410B6Q35210473-92353003-7916-4C7F-9B99-69830038CD7EQ35853990-9AF7D498-6E4E-49A0-AE64-4E7E32F5E22BQ35949356-E7FFE95C-CB4D-4091-A2B6-13E45BA94CA2Q36264921-043AB3B2-004F-4736-8DE4-F80255D0DF27Q36348346-AFACC075-F7D4-451F-BC6F-B2C961446B99Q36760126-2AB0BF83-59E8-477E-8F95-EAD72EE4782FQ37123173-5DE808B4-BA00-4481-A268-784D5623D208Q37272838-F02C3BBC-F604-47EA-A76E-9BE22CD8D074Q37347354-34ABC4BA-A09A-4D78-84D4-2A1144AD0646Q37609090-CED521EF-DDD6-4771-931E-E9582B605879Q37621530-6374665C-6C66-4E68-9E43-7CCB5DDB4794Q38191212-E9657BEA-852C-43F9-8E66-1EC478C49F82Q38546492-DF65D7C8-677C-4749-8CB6-6F0CD52FE7D9Q38645275-2B7AFE61-E342-4D83-BA62-39A90D913C6BQ38787435-30DE19DB-4F16-49BD-B447-AA80BA01FBAAQ39064354-1BEECD1E-6AF3-433E-AC9C-DC2569B3315CQ39180715-D33C83D0-C910-4E96-9FB0-AEACC216A3F8Q39356341-F796C428-F491-4359-816B-E49A1101FF12Q39409371-EA3BA77A-A5BE-4BB3-86E2-442E72ACE74DQ40212331-D2F49425-6869-4160-86FD-C2CE650CFF30Q41375421-0B699B14-70AE-4CB1-9031-512091F58E79Q41493963-5C18237D-EA62-4012-95F4-745343B57939Q41926074-B39FFF18-89A9-4839-97CD-788CF3D87AF6Q42217395-4B4BA13F-67C4-4323-8F17-91C60CE2D35DQ45875010-0AF0E7B4-AC0C-4394-9D4C-0A6DEA9BC116Q49894243-A083C0C0-6689-4BDF-A99A-8D72BABB5853
P2860
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Single amino acid modification ...... n and humoral immune profiles.
@ast
Single amino acid modification ...... n and humoral immune profiles.
@en
type
label
Single amino acid modification ...... n and humoral immune profiles.
@ast
Single amino acid modification ...... n and humoral immune profiles.
@en
prefLabel
Single amino acid modification ...... n and humoral immune profiles.
@ast
Single amino acid modification ...... n and humoral immune profiles.
@en
P2093
P2860
P356
P1433
P1476
Single amino acid modification ...... n and humoral immune profiles.
@en
P2093
Aravind Asokan
Chengwen Li
Dawn E Bowles
Joseph Rabinowitz
Matthew L Hirsch
Nina Diprimio
Paul E Monahan
R Jude Samulski
P2860
P304
P356
10.1128/JVI.00675-12
P407
P577
2012-05-16T00:00:00Z